Global Sustained Release Injectables Market 2019 by Manufacturers, Regions, Type and Application, Forecast to 2024

  • receipt Report ID : 221436
  • calendar_today Published On: Dec, 2019
  • file_copy Pages: 100
  • list Medical Devices

Description

Scope of the Report:

The worldwide market for Sustained Release Injectables is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.

This report focuses on the Sustained Release Injectables in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

AstraZeneca

Biomarin

Roche

Eli Lilly

Avadel

Sanofi

Critical Pharmaceuticals

Aurobindo

Novartis

Camurus

Alkermes

Taiwan Liposome Company

Amylin

Ascendis Pharma

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Naltrexone

Exenatide

Estradiol

Other

Market Segment by Applications, can be divided into

Diabetes

Leukemia

Acromegaly

Other

The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Sustained Release Injectables product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Sustained Release Injectables, with price, sales, revenue and global market share of Sustained Release Injectables in 2017 and 2018.

Chapter 3, the Sustained Release Injectables competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Sustained Release Injectables breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.

Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.

Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.

Chapter 12, Sustained Release Injectables market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.

Chapter 13, 14 and 15, to describe Sustained Release Injectables sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Sustained Release Injectables Introduction

1.2 Market Analysis by Type

1.2.1 Naltrexone

1.2.2 Exenatide

1.2.3 Estradiol

1.2.4 Other

1.3 Market Analysis by Applications

1.3.1 Diabetes

1.3.2 Leukemia

1.3.3 Acromegaly

1.3.4 Other

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2014-2024)

1.4.1.2 Canada Market States and Outlook (2014-2024)

1.4.1.3 Mexico Market States and Outlook (2014-2024)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2014-2024)

1.4.2.2 France Market States and Outlook (2014-2024)

1.4.2.3 UK Market States and Outlook (2014-2024)

1.4.2.4 Russia Market States and Outlook (2014-2024)

1.4.2.5 Italy Market States and Outlook (2014-2024)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2014-2024)

1.4.3.2 Japan Market States and Outlook (2014-2024)

1.4.3.3 Korea Market States and Outlook (2014-2024)

1.4.3.4 India Market States and Outlook (2014-2024)

1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2014-2024)

1.4.4.2 Egypt Market States and Outlook (2014-2024)

1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)

1.4.4.4 South Africa Market States and Outlook (2014-2024)

1.4.4.5 Turkey Market States and Outlook (2014-2024)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 AstraZeneca

2.1.1 Business Overview

2.1.2 Sustained Release Injectables Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 AstraZeneca Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.2 Biomarin

2.2.1 Business Overview

2.2.2 Sustained Release Injectables Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Biomarin Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.3 Roche

2.3.1 Business Overview

2.3.2 Sustained Release Injectables Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Roche Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.4 Eli Lilly

2.4.1 Business Overview

2.4.2 Sustained Release Injectables Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Eli Lilly Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.5 Avadel

2.5.1 Business Overview

2.5.2 Sustained Release Injectables Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Avadel Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.6 Sanofi

2.6.1 Business Overview

2.6.2 Sustained Release Injectables Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Sanofi Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.7 Critical Pharmaceuticals

2.7.1 Business Overview

2.7.2 Sustained Release Injectables Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Critical Pharmaceuticals Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.8 Aurobindo

2.8.1 Business Overview

2.8.2 Sustained Release Injectables Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Aurobindo Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.9 Novartis

2.9.1 Business Overview

2.9.2 Sustained Release Injectables Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Novartis Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.10 Camurus

2.10.1 Business Overview

2.10.2 Sustained Release Injectables Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Camurus Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.11 Alkermes

2.11.1 Business Overview

2.11.2 Sustained Release Injectables Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Alkermes Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.12 Taiwan Liposome Company

2.12.1 Business Overview

2.12.2 Sustained Release Injectables Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Taiwan Liposome Company Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.13 Amylin

2.13.1 Business Overview

2.13.2 Sustained Release Injectables Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Amylin Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

2.14 Ascendis Pharma

2.14.1 Business Overview

2.14.2 Sustained Release Injectables Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Ascendis Pharma Sustained Release Injectables Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)

3 Global Sustained Release Injectables Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)

3.1 Global Sustained Release Injectables Sales and Market Share by Manufacturer (2017-2018)

3.2 Global Sustained Release Injectables Revenue and Market Share by Manufacturer (2017-2018)

3.3 Market Concentration Rate

3.3.1 Top 3 Sustained Release Injectables Manufacturer Market Share in 2018

3.3.2 Top 6 Sustained Release Injectables Manufacturer Market Share in 2018

3.4 Market Competition Trend

4 Global Sustained Release Injectables Market Analysis by Regions

4.1 Global Sustained Release Injectables Sales, Revenue and Market Share by Regions

4.1.1 Global Sustained Release Injectables Sales and Market Share by Regions (2014-2019)

4.1.2 Global Sustained Release Injectables Revenue and Market Share by Regions (2014-2019)

4.2 North America Sustained Release Injectables Sales and Growth Rate (2014-2019)

4.3 Europe Sustained Release Injectables Sales and Growth Rate (2014-2019)

4.4 Asia-Pacific Sustained Release Injectables Sales and Growth Rate (2014-2019)

4.5 South America Sustained Release Injectables Sales and Growth Rate (2014-2019)

4.6 Middle East and Africa Sustained Release Injectables Sales and Growth Rate (2014-2019)

5 North America Sustained Release Injectables by Country

5.1 North America Sustained Release Injectables Sales, Revenue and Market Share by Country

5.1.1 North America Sustained Release Injectables Sales and Market Share by Country (2014-2019)

5.1.2 North America Sustained Release Injectables Revenue and Market Share by Country (2014-2019)

5.2 United States Sustained Release Injectables Sales and Growth Rate (2014-2019)

5.3 Canada Sustained Release Injectables Sales and Growth Rate (2014-2019)

5.4 Mexico Sustained Release Injectables Sales and Growth Rate (2014-2019)

6 Europe Sustained Release Injectables by Country

6.1 Europe Sustained Release Injectables Sales, Revenue and Market Share by Country

6.1.1 Europe Sustained Release Injectables Sales and Market Share by Country (2014-2019)

6.1.2 Europe Sustained Release Injectables Revenue and Market Share by Country (2014-2019)

6.2 Germany Sustained Release Injectables Sales and Growth Rate (2014-2019)

6.3 UK Sustained Release Injectables Sales and Growth Rate (2014-2019)

6.4 France Sustained Release Injectables Sales and Growth Rate (2014-2019)

6.5 Russia Sustained Release Injectables Sales and Growth Rate (2014-2019)

6.6 Italy Sustained Release Injectables Sales and Growth Rate (2014-2019)

7 Asia-Pacific Sustained Release Injectables by Country

7.1 Asia-Pacific Sustained Release Injectables Sales, Revenue and Market Share by Country

7.1.1 Asia-Pacific Sustained Release Injectables Sales and Market Share by Country (2014-2019)

7.1.2 Asia-Pacific Sustained Release Injectables Revenue and Market Share by Country (2014-2019)

7.2 China Sustained Release Injectables Sales and Growth Rate (2014-2019)

7.3 Japan Sustained Release Injectables Sales and Growth Rate (2014-2019)

7.4 Korea Sustained Release Injectables Sales and Growth Rate (2014-2019)

7.5 India Sustained Release Injectables Sales and Growth Rate (2014-2019)

7.6 Southeast Asia Sustained Release Injectables Sales and Growth Rate (2014-2019)

8 South America Sustained Release Injectables by Country

8.1 South America Sustained Release Injectables Sales, Revenue and Market Share by Country

8.1.1 South America Sustained Release Injectables Sales and Market Share by Country (2014-2019)

8.1.2 South America Sustained Release Injectables Revenue and Market Share by Country (2014-2019)

8.2 Brazil Sustained Release Injectables Sales and Growth Rate (2014-2019)

8.3 Argentina Sustained Release Injectables Sales and Growth Rate (2014-2019)

8.4 Colombia Sustained Release Injectables Sales and Growth Rate (2014-2019)

9 Middle East and Africa Sustained Release Injectables by Countries

9.1 Middle East and Africa Sustained Release Injectables Sales, Revenue and Market Share by Country

9.1.1 Middle East and Africa Sustained Release Injectables Sales and Market Share by Country (2014-2019)

9.1.2 Middle East and Africa Sustained Release Injectables Revenue and Market Share by Country (2014-2019)

9.2 Saudi Arabia Sustained Release Injectables Sales and Growth Rate (2014-2019)

9.3 Turkey Sustained Release Injectables Sales and Growth Rate (2014-2019)

9.4 Egypt Sustained Release Injectables Sales and Growth Rate (2014-2019)

9.5 Nigeria Sustained Release Injectables Sales and Growth Rate (2014-2019)

9.6 South Africa Sustained Release Injectables Sales and Growth Rate (2014-2019)

10 Global Sustained Release Injectables Market Segment by Type

10.1 Global Sustained Release Injectables Sales, Revenue and Market Share by Type (2014-2019)

10.1.1 Global Sustained Release Injectables Sales and Market Share by Type (2014-2019)

10.1.2 Global Sustained Release Injectables Revenue and Market Share by Type (2014-2019)

10.2 Naltrexone Sales Growth and Price

10.2.1 Global Naltrexone Sales Growth (2014-2019)

10.2.2 Global Naltrexone Price (2014-2019)

10.3 Exenatide Sales Growth and Price

10.3.1 Global Exenatide Sales Growth (2014-2019)

10.3.2 Global Exenatide Price (2014-2019)

10.4 Estradiol Sales Growth and Price

10.4.1 Global Estradiol Sales Growth (2014-2019)

10.4.2 Global Estradiol Price (2014-2019)

10.5 Other Sales Growth and Price

10.5.1 Global Other Sales Growth (2014-2019)

10.5.2 Global Other Price (2014-2019)

11 Global Sustained Release Injectables Market Segment by Application

11.1 Global Sustained Release Injectables Sales Market Share by Application (2014-2019)

11.2 Diabetes Sales Growth (2014-2019)

11.3 Leukemia Sales Growth (2014-2019)

11.4 Acromegaly Sales Growth (2014-2019)

11.5 Other Sales Growth (2014-2019)

12 Sustained Release Injectables Market Forecast (2019-2024)

12.1 Global Sustained Release Injectables Sales, Revenue and Growth Rate (2019-2024)

12.2 Sustained Release Injectables Market Forecast by Regions (2019-2024)

12.2.1 North America Sustained Release Injectables Market Forecast (2019-2024)

12.2.2 Europe Sustained Release Injectables Market Forecast (2019-2024)

12.2.3 Asia-Pacific Sustained Release Injectables Market Forecast (2019-2024)

12.2.4 South America Sustained Release Injectables Market Forecast (2019-2024)

12.2.5 Middle East and Africa Sustained Release Injectables Market Forecast (2019-2024)

12.3 Sustained Release Injectables Market Forecast by Type (2019-2024)

12.3.1 Global Sustained Release Injectables Sales Forecast by Type (2019-2024)

12.3.2 Global Sustained Release Injectables Market Share Forecast by Type (2019-2024)

12.4 Sustained Release Injectables Market Forecast by Application (2019-2024)

12.4.1 Global Sustained Release Injectables Sales Forecast by Application (2019-2024)

12.4.2 Global Sustained Release Injectables Market Share Forecast by Application (2019-2024)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Sustained Release Injectables Picture

Table Product Specifications of Sustained Release Injectables

Figure Global Sales Market Share of Sustained Release Injectables

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery